You are here
- Home
- Last 30 days trials
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients with Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants.
- Disease
- depression
- Drug Name
- AZD6765
- Generic Name
- AZD6765
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- IIb
- Start Date
- Jan 18, 1971
- Study Name
- D6702C00031
- Study Id
- D6702C00031
- ClinicalTrials.gov ID
- NCT01482221
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
